Canadian Healthcare Professionals' Views and Attitudes toward Risk-Stratified Breast Cancer Screening.
breast cancer
health policies
health professionals
implementation
national health systems
personalized screening
perspectives
risk-based strategy
screening programs
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
21 Jun 2023
21 Jun 2023
Historique:
received:
14
04
2023
revised:
02
06
2023
accepted:
19
06
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Given the controversy over the effectiveness of age-based breast cancer (BC) screening, offering risk-stratified screening to women may be a way to improve patient outcomes with detection of earlier-stage disease. While this approach seems promising, its integration requires the buy-in of many stakeholders. In this cross-sectional study, we surveyed Canadian healthcare professionals about their views and attitudes toward a risk-stratified BC screening approach. An anonymous online questionnaire was disseminated through Canadian healthcare professional associations between November 2020 and May 2021. Information collected included attitudes toward BC screening recommendations based on individual risk, comfort and perceived readiness related to the possible implementation of this approach. Close to 90% of the 593 respondents agreed with increased frequency and earlier initiation of BC screening for women at high risk. However, only 9% agreed with the idea of not offering BC screening to women at very low risk. Respondents indicated that primary care physicians and nurse practitioners should play a leading role in the risk-stratified BC screening approach. This survey identifies health services and policy enhancements that would be needed to support future implementation of a risk-stratified BC screening approach in healthcare systems in Canada and other countries.
Identifiants
pubmed: 37511640
pii: jpm13071027
doi: 10.3390/jpm13071027
pmc: PMC10381377
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : CIHR
ID : 155865
Pays : Canada
Références
PLoS One. 2018 Jun 1;13(6):e0197772
pubmed: 29856760
Genet Test Mol Biomarkers. 2013 Mar;17(3):219-25
pubmed: 23390885
Hum Resour Health. 2017 Jun 27;15(1):42
pubmed: 28655303
PLoS One. 2014 Feb 03;9(2):e86858
pubmed: 24498285
Genet Med. 2022 Nov;24(11):2380-2388
pubmed: 36057905
Eur J Gen Pract. 2009 Dec;15(4):231-42
pubmed: 20055722
Breast. 2019 Feb;43:39-47
pubmed: 30445378
PLoS One. 2022 Feb 4;17(2):e0263788
pubmed: 35120169
J Natl Cancer Inst. 2017 Jan 27;109(5):
pubmed: 28130475
Eur J Health Econ. 2021 Nov;22(8):1311-1344
pubmed: 34342797
Ann Intern Med. 2012 May 1;156(9):609-17
pubmed: 22547470
Nurs Forum. 2008 Jul-Sep;43(3):144-50
pubmed: 18715347
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
BMC Womens Health. 2017 Dec 16;17(1):132
pubmed: 29246147
Implement Sci. 2010 Jul 13;5:53
pubmed: 20626858
J Natl Cancer Inst. 2021 Apr 6;113(4):434-442
pubmed: 32853342
Curr Oncol. 2016 Dec;23(6):e615-e625
pubmed: 28050152
J Med Screen. 2020 Sep;27(3):138-145
pubmed: 31701797
J Pers Med. 2021 Feb 02;11(2):
pubmed: 33540785
JAMA Oncol. 2018 Nov 1;4(11):1504-1510
pubmed: 29978189
BMC Womens Health. 2022 May 2;22(1):142
pubmed: 35501791
NPJ Breast Cancer. 2017 Sep 13;3:34
pubmed: 28944288
Womens Health (Lond). 2021 Jan-Dec;17:17455065211009746
pubmed: 33877937
PLoS One. 2019 Dec 16;14(12):e0226352
pubmed: 31841563
Int J Environ Res Public Health. 2022 Jan 27;19(3):
pubmed: 35162427
Nat Rev Clin Oncol. 2020 Nov;17(11):687-705
pubmed: 32555420
Public Health Rev. 2019 Feb 28;40:2
pubmed: 30858992
BMC Fam Pract. 2021 Jul 1;22(1):141
pubmed: 34210270
BMC Cancer. 2022 May 6;22(1):507
pubmed: 35524202
Healthc Policy. 2019 Nov;15(2):39-54
pubmed: 32077844
Sante Publique. 2016 May-Jun;28(3):353-61
pubmed: 27531433
Br J Cancer. 2013 Jun 11;108(11):2205-40
pubmed: 23744281
Acta Oncol. 2016;55(1):45-51
pubmed: 25990635
J Pers Med. 2021 Jun 04;11(6):
pubmed: 34199804
Milbank Q. 2004;82(4):581-629
pubmed: 15595944
Int J Cancer. 2020 Dec 1;147(11):3059-3067
pubmed: 32484237
Breast. 2015 Jun;24(3):237-41
pubmed: 25708717
Ann Intern Med. 2016 Nov 15;165(10):700-712
pubmed: 27548583
BMC Cancer. 2020 Jul 22;20(1):680
pubmed: 32698780
Genes (Basel). 2023 Mar 16;14(3):
pubmed: 36981003
Breast. 2014 Oct;23(5):644-50
pubmed: 24998452
J Pers Med. 2015 Jun 09;5(2):191-212
pubmed: 26068647